PG
STJ

PEAK6 Group’s St Jude Medical STJ Stock Holding History

PEAK6 Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-59,968
Closed -$4.81M – 5540
2016
Q4 		$4.81M Buy
59,968
+6,457
+12% +$513K 0.03% 732
2016
Q3 		$4.27M Buy
+53,511
New +$4.32M 0.03% 778
2015
Q1 		– Sell
-19,381
Closed -$1.29M – 5605
2014
Q4 		$1.26M Buy
+19,381
New +$1.25M 0.01% 1739

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

PEAK6 Group's STJ Position: Q1 2017 in Review

PEAK6 Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 59,968 shares — an estimated $4.81M sold.

PEAK6 Group first reported a position in STJ in Q4 2014 and held it in 3 quarters. The position peaked at $4.81M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • PEAK6 Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 59,968 St Jude Medical shares in Q1 2017, an estimated $4.81M.
  • PEAK6 Group first reported a position in St Jude Medical in Q4 2014 and held it in 3 quarters.
  • PEAK6 Group's St Jude Medical position peaked at $4.81M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.